Skip to main navigation Skip to search Skip to main content

Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Abstract

Background: Serum cystatin C has been proposed as an endogenous marker of glomerular filtration rate (GFR) because it shows a correlation with the albumin to creatinine ratio (ACR) in diabetic nephropathy. The aim of this study was to examine the usefulness of cystatin C as an early marker of diabetic nephropathy. Methods: From February 2010 to July 2010, 205 outpatients with normo- or microalbuminuria and chronic kidney disease (CKD) of stage III or less were included in this study. Various renal markers including serum cystatin C and ACR were evaluated. Results: In the ROC curve analysis, cystatin C showed a performance similar to that of serum creatinine. In addition, cystatin C levels increased with increasing CKD stage I to III and from normo- to microalbuminuria and showed a positive correlation with ACR. In a comparison of renal function markers in diabetic patients according to serum cystatin C level, all markers including ACR, serum creatinine, and eGFR showed significant differences between patients with cystatin C level < 1.06 mg/L and those with cystatin C ≥ 1.06 mg/L. Conclusions: Serum cystatin C is a useful marker of early renal impairment in type 2 diabetic patients because it reflects both a decrease in GFR and elevated ACR.

Original languageEnglish
Pages (from-to)1221-1229
Number of pages9
JournalClinical Laboratory
Volume59
Issue number11-12
DOIs
Publication statusPublished - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • ACR (albumin to creatinine ratio)
  • Albuminuria
  • Cystatin C
  • Diabetic nephropathy
  • GFR (glomerular filtration rate)

Fingerprint

Dive into the research topics of 'Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes'. Together they form a unique fingerprint.

Cite this